Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

ARKG vs HELX overlap: 26% of top holdings shared

Bottom line

How much do ARKG and HELX overlap?

26% of their top holdings overlap by weight. 8 securities appear in both funds' top 25, making up 34.7% of ARKG's assets and 31.8% of HELX's. They are substantially different portfolios, so owning both adds real diversification.

Updated Nov 22, 2026

Overlap at a glance

ARKGHELX
Weight overlap (top 25)26%
Shared holdings8
Weight in shared holdings34.7%31.8%
Total positions3363
Expense ratio0.75%0.5%
Holdings as ofJul 31, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Holdings ARKG and HELX have in common

Holding% of ARKG% of HELXOverlap
Twist Bioscience Corp TWST7.73%2.85%2.85%
Tempus Ai Inc TEM6.56%1.95%1.95%
Guardant Health Inc GH4.74%9.09%4.74%
Eli Lilly & Company LLY4.68%2.95%2.95%
Natera Inc NTRA4.13%7.46%4.13%
Adaptive Biotechnologies Corp ADPT2.57%3.99%2.57%
Veracyte Inc VCYT2.55%1.64%1.64%
Ionis Pharmaceuticals Inc IONS1.77%1.91%1.77%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in ARKG

  1. 10x Genomics Inc — 9.39%
  2. Crispr Therapeutics Ag — 6.29%
  3. Personalis Inc — 5.47%
  4. Absci Corp — 5.14%
  5. Illumina Inc — 4.74%
  6. Caredx Inc — 4.30%
  7. Beam Therapeutics Inc — 3.78%
  8. Compass Pathways Plc — 3.25%
  9. Recursion Pharmaceuticals Inc — 2.63%
  10. Nurix Therapeutics Inc — 2.51%
  11. Butterfly Network Inc — 2.18%
  12. Schrodinger Inc — 1.99%
  13. Genedx Holdings Corp — 1.87%
  14. Intellia Therapeutics Inc — 1.83%
  15. Alamar Biosciences Inc — 1.56%

Only in HELX

  1. Krystal Biotech Inc — 6.33%
  2. Ligand Pharmaceuticals Inc — 4.62%
  3. United Therapeutics Corp — 3.51%
  4. Bridgebio Pharma Inc — 3.50%
  5. Vertex Pharmaceuticals Inc — 2.75%
  6. Astrazeneca Plc — 2.70%
  7. Travere Therapeutics Inc — 2.59%
  8. Insmed Inc — 2.44%
  9. Samsung Biologics Co Ltd — 2.26%
  10. Corteva Inc — 2.25%
  11. Medpace Holdings Inc — 2.15%
  12. Alnylam Pharmaceuticals Inc — 1.96%
  13. Neurocrine Biosciences Inc — 1.84%
  14. Regeneron Pharmaceuticals Inc — 1.80%
  15. Argenx Se — 1.64%

Asset mix

Asset typeARKGHELX
Stocks99.6%97.9%
Preferred stock—0.9%
Cash & short-term funds0.2%—

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Country mix

CountryARKGHELX
US90.3%86.6%
CH6.3%1.2%
GB3.3%3.0%
KR—2.6%
DE—2.2%
NL—2.1%
IE—0.8%
SG—0.1%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do ARKG and HELX overlap?
About 26% by weight. 8 securities appear in both funds' top 25 holdings; they make up 34.7% of ARKG's assets and 31.8% of HELX's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do ARKG and HELX have in common?
The largest shared holdings are Guardant Health Inc, Natera Inc, Eli Lilly & Company, Twist Bioscience Corp, Adaptive Biotechnologies Corp.
Should I own both ARKG and HELX?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, ARKG or HELX?
HELX is broader, with 63 positions versus 33 for ARKG. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.